Institutional investors remain committed to Asia even though distributions from funds targeting the region can be slower to come than those in the US and Western Europe, the AVCJ Forum heard.
“Today, emerging markets are 45-55% of GDP, depending on whether you calculate it on a nominal or PPP basis, but only 14% of private equity fundraising goes to these markets,” said Nicholas Vickery,...
Indonesia’s Kejora Ventures and Korea’s InterVest have jointly led a $30 million Series B investment in Malaysian drone technology supplier Aerodyne.
Tencent Holdings, JS Capital, Tiger Global Management, and Prime Venture Partners have provided a $56 million Series B round to India’s MyGate, a security app for gated communities.
Ansun BioPharma, a US-based drug developer led by a former executive at healthcare-focused VC firms Caduceus Asia Partners and OrbiMed, has raised $80 million in Series B funding from a predominantly Chinese investor base.
US-based mid-market buyout firm Cornell Capital has made its first investment in Asia with a commitment to Taiwan-headquartered cable manufacturer Lorom Holding.